Insider Cluster (1 insider) ·Filed Mar 10, 2026
Insider cluster: 2 insiders, $1.3M total
Actionable Insight • Neutral
The sale is minor relative to company size and likely routine; monitor for additional sales or participation from other insiders to assess potential concern.
Final — all horizons settled through T+60d
BBIO ▼ -11.89% at T+60d
NEUTRAL call ✗ call lost -11.89% · α vs SPY -23.30% · entry $74.32 → $65.48
T+1d
-3.94%
call -3.94% · α -3.84%
$71.39
settled 7mo ago
T+5d
-4.55%
call -4.55% · α -3.64%
$70.94
settled 7mo ago
T+20d
-0.24%
call -0.24% · α -0.09%
$74.14
settled 6mo ago
T+60d
-11.89%
call -11.89% · α -23.30%
$65.48
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
BridgeBio Pharma CEO Kumar Neil was granted a total of 144,883 shares in non-cash awards and sold 9,690 shares in an open-market transaction worth approximately $662,441. The sale represents a small fraction of the company's market cap and is likely part of a pre-arranged trading plan.
Key Financial Metrics
Direction
selling
Total Value
$662.4K
Insiders
1
Key Facts
- CEO Kumar Neil received two non-cash stock awards totaling 144,883 shares with no economic value at grant.
- CEO sold 9,690 shares in an open-market transaction at $68.3634 per share, totaling $662,441.
- Total value of open-market sale is $662,441, representing approximately 0.0049% of BBIO's $13.6B market cap.
Financial Impact
$662,441 in open-market sales; no financial impact from non-cash grants
insider ownershipshare count (dilution from grants)
Risk Factors
- Non-cash grants may lead to future dilution, though standard for executive compensation.
- Single insider sale, even if small, could signal reduced conviction if followed by further selling.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-BBIO-1773952120485 |
26 reports for BBIO
90% Hit rate best @ T+60▲ +26.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $76.59 $65.97 | ▼ −13.87% | ▼ −13.68% | $67.47 (−11.90%) |
Aug 26, 2026 5w ago | Press Release | $79.37 $66.28 | ▼ −16.49% | ▼ −16.72% | $67.47 (−14.99%) |
Aug 22, 2026 5w ago | Institutional Cluster | $81.07 $69.23 | ▼ −14.60% | ▼ −15.92% | $67.47 (−16.77%) |
Aug 17, 2026 6w ago | 8-K | $79.89 $72.38 | ▼ −9.40% | ▼ −7.87% | $67.47 (−15.54%) |
Aug 13, 2026 7w ago | Press Release | $79.86 $72.38 | ▲ +9.37% | ▲ +7.38% | $67.47 (+15.51%) |
Aug 10, 2026 7w ago | 8-K | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Aug 10, 2026 7w ago | Press Release | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Jul 13, 2026 11w ago | Insider Cluster | $83.08 $84.67 | ▲ +1.91% | ▼ −1.27% | $67.47 (−18.78%) |
Jun 28, 2026 13w ago | Press Release | $72.01 $84.02 | ▲ +16.68% | ▲ +16.96% | $67.47 (−6.30%) |
Jun 24, 2026 14w ago | 144 | $69.69 $82.93 | ▲ +19.00% | ▲ +18.47% | $67.47 (−3.18%) |
Showing 10 of 26
US Market Status
Market Open — Closes in 2h 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access